Law360, New York (March 4, 2011, 8:38 PM EST) -- Mylan Pharmaceuticals Inc., Teva Biopharmaceuticals USA Inc. and Qualitest Pharmaceuticals Inc. are facing a putative class action in Maryland for allegedly failing to address the potential risks of their now-recalled generic versions of painkillers Darvocet and Darvon.
Despite significant evidence dating back to the 1970s highlighting the inefficacy and risk of cardiac side effects associated with the drugs' active ingredient propoxyphene, the defendants failed to thoroughly investigate these claims and continued marketing their products as safe and effective for use, the three named plaintiffs allege in...
Mylan, Others Hit With Class Action Over Painkillers
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
